BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18344087)

  • 1. [Prognostic value of cyclin E and its relation to blood vessel invasion in rectal cancer].
    Zhou YJ; Wan FL; Yao LH; Feng LY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):167-71. PubMed ID: 18344087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
    Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
    Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of cyclin E expression in operable breast cancer.
    Potemski P; Kusińska R; Pasz-Walczak G; Piekarski JH; Watała C; Płuciennik E; Bednarek AK; Kordek R
    Med Sci Monit; 2009 Feb; 15(2):MT34-40. PubMed ID: 19179977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
    Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L
    Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
    Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
    Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
    Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
    Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of invasion, metastasis, and prognosis in low and middle rectal cancer].
    He WJ; Wang L; Hu H; Kang SY; Qian HX; Xu FM
    Ai Zheng; 2002 Nov; 21(11):1222-5. PubMed ID: 12526220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
    Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
    Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
    Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
    Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
    Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
    Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.
    Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C
    Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients.
    Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG
    Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
    Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
    Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.